Refills offers access to branded options including Ozempic, Wegovy, Zepbound, and Saxenda, as well as a compounded semaglutide injectable (Personalized GLP-1)
no regulatory body Health Canada, the FDA, the EMA, the TGA, or any equivalent has approved the compound as a drug for human or veterinary use
Understanding the GLP-1 consumer The GLP-1 era has given rise to multiple distinct consumer types, each with shared, yet nuanced, nutritional needs: Consumers currently using GLP-1 therapies face unique challenges, including appetite suppression that can make meeting nutritional requirements difficult, potential gastrointestinal side effects and concerns about maintaining muscle mass during weight loss
If you do not have coverage, Ro's total out-of-pocket costs can exceed Peak Wellness considerably